Chemical Structure : ZG-2686
货号: PC-26180Not For Human Use, Lab Use Only.
ZG-2686 is a potent HIF-2α agonist with EC50 of 0.25 uM, Emax=375.7%, synergistically enhances HIF-2α-dependent EPO gene expression when combined with prolyl hydroxylase domain (PHD) inhibitor Vadadustat.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ZG-2686 is a potent HIF-2α agonist with EC50 of 0.25 uM, Emax=375.7%, synergistically enhances HIF-2α-dependent EPO gene expression when combined with prolyl hydroxylase domain (PHD) inhibitor Vadadustat.
| 分子量 | 317.15 | |
| 分子式 | C13H9BrN4O | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Yinli Gao, et al. J Med Chem. 2025 Dec 11;68(23):25569-25589.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright